Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NATALI M BALOG

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1578552386
CMS profile
252380
Location
GRANGER, IN

General Payments · PY2018–2024

$3,846.05

  • Reported across 245 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$732.27

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $633.27 35
Education $99.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $201.85 15
Janssen Biotech, Inc. $124.19 2
NOVARTIS PHARMACEUTICALS CORPORATION $110.32 5
UCB, Inc. $71.88 3
Amgen Inc. $59.29 3
Radius Health, Inc. $37.17 2
GENZYME CORPORATION $29.98 1
Lilly USA, LLC $26.08 1
Genentech USA, Inc. $21.68 1
Acerta Pharma LLC $18.94 1
E.R. Squibb & Sons, L.L.C. $16.70 1
GlaxoSmithKline, LLC. $14.19 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12.73 1
PY2019 $107.99 7
PY2020 $369.85 26
PY2021 $1,074.33 71
PY2022 $745.90 60
PY2023 $802.98 44
PY2024 $732.27 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.57 01/10/2024 Food and Beverage Undisputed 01/23/2026 1103272869 CMS
ABBVIE INC. $6.70 01/24/2024 Food and Beverage Undisputed 01/23/2026 1103272871 CMS
ABBVIE INC. $15.40 03/13/2024 Food and Beverage Undisputed 01/23/2026 1103272873 CMS
ABBVIE INC. $15.01 04/06/2024 Food and Beverage Undisputed 01/23/2026 1103272875 CMS
ABBVIE INC. $19.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 1103272877 CMS
ABBVIE INC. $7.83 04/24/2024 Food and Beverage Undisputed 01/23/2026 1103272879 CMS
ABBVIE INC. $6.62 04/30/2024 Food and Beverage Undisputed 01/23/2026 1103272881 CMS
ABBVIE INC. $15.61 05/24/2024 Food and Beverage Undisputed 01/23/2026 1103272883 CMS
ABBVIE INC. $8.15 06/03/2024 Food and Beverage Undisputed 01/23/2026 1103272885 CMS
ABBVIE INC. $11.53 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103272887 CMS
ABBVIE INC. $11.38 07/23/2024 Food and Beverage Undisputed 01/23/2026 1103272889 CMS
ABBVIE INC. $20.51 07/24/2024 Food and Beverage Undisputed 01/23/2026 1103272891 CMS
ABBVIE INC. $10.78 08/14/2024 Food and Beverage Undisputed 01/23/2026 1103272893 CMS
ABBVIE INC. $27.53 09/12/2024 Food and Beverage Undisputed 01/23/2026 1103272895 CMS
ABBVIE INC. $7.98 11/04/2024 Food and Beverage Undisputed 01/23/2026 1103272897 CMS
Amgen Inc. $16.14 05/15/2024 Food and Beverage Undisputed 01/23/2026 1115438524 CMS
Amgen Inc. $24.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 1115438520 CMS
Amgen Inc. $18.89 12/04/2024 Food and Beverage Undisputed 01/23/2026 1115438515 CMS
AstraZeneca Pharmaceuticals LP $18.94 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105408451 CMS
E.R. Squibb & Sons, L.L.C. $16.70 01/18/2024 Food and Beverage Undisputed 01/23/2026 1101326980 CMS
Genentech USA, Inc. $21.68 07/10/2024 Food and Beverage Undisputed 01/23/2026 1133078327 CMS
GENZYME CORPORATION $29.98 05/01/2024 Food and Beverage Undisputed 01/23/2026 1139852014 CMS
GlaxoSmithKline, LLC. $14.19 02/06/2024 Food and Beverage Undisputed 01/23/2026 1116461640 CMS
Janssen Biotech, Inc. $25.19 03/06/2024 Food and Beverage Undisputed 01/23/2026 1078619465 CMS
Janssen Biotech, Inc. $99.00 04/04/2024 Education Undisputed 01/23/2026 1078619447 CMS
Lilly USA, LLC $26.08 02/20/2024 Food and Beverage Undisputed 01/23/2026 1135280207 CMS
Novartis Pharmaceuticals Corporation $23.01 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086710933 CMS
Novartis Pharmaceuticals Corporation $18.63 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086710935 CMS
Novartis Pharmaceuticals Corporation $25.13 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086710945 CMS
Novartis Pharmaceuticals Corporation $20.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 1086710951 CMS
Novartis Pharmaceuticals Corporation $22.66 11/07/2024 Food and Beverage Undisputed 01/23/2026 1086710975 CMS
Radius Health, Inc. $17.78 01/25/2024 Food and Beverage Undisputed 01/23/2026 1089979008 CMS
Radius Health, Inc. $19.39 11/14/2024 Food and Beverage Undisputed 01/23/2026 1089979002 CMS
UCB, Inc. $23.97 10/16/2024 Food and Beverage Undisputed 01/23/2026 1143408376 CMS
UCB, Inc. $22.19 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143408380 CMS
UCB, Inc. $25.72 12/12/2024 Food and Beverage Undisputed 01/23/2026 1143408385 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.